Dr. Mary Ann Riley, D.O. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1313 National Hwy, Lavale, MD 21502 Phone: 240-362-0288 Fax: 240-362-0052 |
News Archive
One of the most tantalizing developments in anti-cancer therapy over recent years has been the advent of targeted treatments, which have proven highly effective in holding aggressive cancers at bay in certain patients, although typically only for a limited period of time.
Whether you're doing heavy lifting as part of your "honey-do list" around the house or simply lifting groceries out of the car, a back injury can set you on your back (literally) and set you back financially. According to a tally of accident insurance claims submitted in 2009 to Colonial Life & Accident Insurance Company, back sprain or strain was the number-one occurring injury.
GPC Biotech AG has announced that the Oncologic Drugs Advisory Committee (ODAC) for the U.S. Food and Drug Administration (FDA) recommended (12-0) that the FDA should wait for the final survival analysis of the SPARC trial before deciding whether the satraplatin application is approvable for the treatment of hormone-refractory prostate cancer patients whose prior chemotherapy has failed.
Parkinson's, Alzheimer's, stroke, migraine, epilepsy, cancer and autoimmune and metabolic disorders – these are examples of diseases that will be explored by the three Nordic networks that have been granted financial support from the joint Nordic venture "Nordic Centre of Excellence Programme in Molecular Medicine".
Colorado cancer researchers and medical doctors on Wednesday announced they are launching a $200,000 feasibility study as a key step to building the nation's first carbon-ion radiotherapy research and treatment facility in Aurora, where they and colleagues hope to investigate and provide to patients leading-edge radiation therapy that is effective against the deadliest cancers and now is available only in Europe and Japan.
› Verified 1 days ago